Advertisement

Molecular Diagnosis

  • Guadalupe García-Elorriaga
  • Guillermo del Rey-Pineda
Part of the SpringerBriefs in Microbiology book series (BRIEFSMICROBIOL)

Abstract

Isothermal DNA amplification techniques are simple, rapid, cost-effective and they have the equivalent specificity and sensitivity to PCR, thus enabling point-of-care diagnostics for pathogen detection, single nucleotide polymorphism analysis, biomarker detection, etc. Future work in this area should focus on microfluidic adaptations of these techniques with integrated sample preparation and further reduction of cost and result turnover time. Effective amplification of large genomic segments by isothermal methods results in unbiased whole genome amplification from a few homogeneous cells, serving as high-quality single-cell genetic material. This material can then be used for archiving and downstream analysis such as genotyping, comparative genomic hybridization, and single-cell genomics. Immunoassays coupled with isothermal DNA amplification have improved sensitivities compared with traditional enzyme-amplified immunoassays, and improved dynamic range and reproducibility compared to immuno-PCR.

Highly specific isothermal amplification reactions (LAMP, HDA) have allowed the development of assays in which the nonspecific detection of amplicon accumulation is sufficient to indicate the presence of an initial template, allowing real-time fluorescent detection with an intercalating DNA dye such as EvaGreen or SYBR Green I.

Keywords

Isothermal NAAT Molecular diagnosis NAAT PCR 

References

  1. 1.
    Boyle D, Pai M. UNITAID: tuberculosis diagnostics technology and market landscape. 2nd ed. Geneva: WHO; 2013.Google Scholar
  2. 2.
    Fakruddin M, Mazumdar RM, Chowdhury A, Mannan KS. Nucleic acid sequence based amplification (NASBA)-prospects and applications. Int J Life Sci Pharm Res. 2012;2:L106–21.Google Scholar
  3. 3.
    Hopewell PC, Fair EL, Uplekar M. Updating the International Standards for Tuberculosis Care. Entering the era of molecular diagnostics. Ann Am Thorac Soc. 2014;11:277–85. doi: 10.1513/AnnalsATS.201401-004AR.PubMedCrossRefGoogle Scholar
  4. 4.
    Kalyan Kumar CH, Mahesh K, Mohan Reddy N. Use of loop-mediated isothermal amplification of DNA for the rapid detection of HIV/AIDS related opportunistic infections (CMV &TB) in clinical specimens. J AIDS Clin Res. 2012;3:154.Google Scholar
  5. 5.
    McCalla SE, Ong C, Sarma A, Opal SM, Artenstein AW, Tripathi A. A simple method for amplifying RNA targets (SMART). J Mol Diagn. 2012;14:328–35.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Sharma SK, Mohan A. Tuberculosis: from an incurable scourge to a curable disease—journey over a millennium. Indian J Med Res. 2013;137:455–93.PubMedCentralPubMedGoogle Scholar
  7. 7.
    Smith JH, Beals TP. Detection of nucleic acid targets using ramified rolling circle DNA amplification: a single nucleotide polymorphism assay model. PLoS One. 2013;8:e65053.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014;1, CD009593.PubMedGoogle Scholar
  9. 9.
    The Gates Foundation. Public-private partnership announces immediate 40 percent cost reduction for rapid TB test. 2012. http://www.gatesfoundation.org/press-releases/Pages/public-private-partnership-40-percent-reduction-TBtest.aspx. Accessed 25 Mar 2015.
  10. 10.
    World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update WHO/HTM/TB/2013.14. Geneva: World Health Organization; 2013a.Google Scholar
  11. 11.
    World Health Organization. Global tuberculosis report 2013. WHO/HTM/TB/2013.11. Geneva: World Health Organization; 2013b.Google Scholar
  12. 12.
    World Health Organization. Policy update: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert® MTB/RIF system for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Geneva: WHO; 2013c. http://www.stoptb.org/wg/gli/assets/documents/WHO%20Policy%20Statement%20on%20Xpert%20MTB-RIF%202013%20pre%20publication%2022102013.pdf. Accessed 25 Mar 2015.
  13. 13.
    World Health Organization. The use of a commercial loop-mediated isothermal amplification assay (TB-LAMP) for the detection of tuberculosis. Expert group meeting report. Geneva: World Health Organization; 2013d.Google Scholar
  14. 14.
    Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M et al. Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2013. Jan 31;1:CD009593. doi:10.1002/14651858.CD009593.pub2. Review. Update in: Cochrane Database Sys Rev. 2014:1:CD009593.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Guadalupe García-Elorriaga
    • 1
  • Guillermo del Rey-Pineda
    • 2
  1. 1.Mexican Social Security Institute, IMSSNational Medical Center La Raza, CMNRMexico CityMexico
  2. 2.Department of InfectologyFederico Gomez Children’s HospitalMexico CityMexico

Personalised recommendations